RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow
Status:
Recruiting
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the therapeutic activity and side effects of 16 mg/day
dexamethasone in comparison to equivalent dose of MP (1mg/kg/day)for the management of
COVID-19 infected patients.Moreover, and according to the importance of the IL-6/STAT-3 in
triggering the inflammatory cascade and as the miRNAs are considered as prognostic markers,
hence, the study aims also to study the impact of the used regimens on these biomarkers